2-Fluoro-6-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 97%, 5g

METHYL 5-FLUORO-2-FORMYLBENZOATE, 95.0%, 100mg

N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyldimethylsilyl)-L-homoserine, 97%, 1g

3-(5-CHLORO-2-HYDROXYBENZYL)-5-(4-(TRIFLUOROMETHYL)PHENYL)-1,3,4-OXADIAZOL-2(3H)-ONE, 95%, 250mg

trans-Styrylacetic acid, 99.0%, 5g

1-(1H-Benzoimidazol-5-yl)-ethanone, 95.0%, 1g

Furo[3,2-d]pyrimidin-4(3H)-one, 95.0%, 100mg

4,4-Difluorocyclohexylamine hydrochloride, 97.0%, 1g

Tri-O-benzyl-D-glucal>95.0%(HPLC)1g

2,4-Difluorophenylisocyanate, 97.0%, 5g

(3-((3,5-Dimethoxybenzyl)oxy)-2,6-difluorophenyl)boronic acid, 95%, 1g

tert-Butyl (2R,5S)-5-hydroxy-2-methylpiperidine-1-carboxylate, 97%, 100mg

D(-)-Salicine, ROTICHROM® CHR, 5 g, emballage plastique.